Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Lung Cancer |
Free Subscription
2 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Editorial Comment: Implementing an End-to-End Deep Learning Model in the Task of
Differentiating Pure Ground-Glass Nodules on Chest CT.
AJR Am J Roentgenol. 2023 Aug 2. doi: 10.2214/AJR.23.30002.
PubMed
Lung-PNet: An Automated Deep Learning Model for the Diagnosis of Invasive
Adenocarcinoma in Pure Ground-Glass Nodules on Chest CT.
AJR Am J Roentgenol. 2023 Jul 26. doi: 10.2214/AJR.23.29674.
PubMed
Abstract available
Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact
Overall Survival: A Propensity Score-matched NCDB Analysis.
Am J Clin Oncol. 2023;46:503-511.
PubMed
Abstract available
Navigating into a stormy sea: liquid biopsy enters peri-operative management in
early-stage non-small cell lung cancer.
Ann Oncol. 2024;35:147-149.
PubMed
Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After
Surgery: A National Real-World Cohort Study.
Ann Surg Oncol. 2024 Feb 9. doi: 10.1245/s10434-024-14983.
PubMed
Abstract available
ASO Visual Abstract: CT-Based Deep Learning Model for Spread Through Air Spaces
Prediction in Ground-Glass Predominant Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:1597-1598.
PubMed
ASO Visual Abstract: Distinct Recurrence Pattern and Survival Outcomes of
Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy
in Intrapulmonary Spread.
Ann Surg Oncol. 2024;31:1591-1592.
PubMed
ASO Author Reflections: Should We Prefer Robotic over Thoracoscopic Surgery for
Sublobar Resection in Octogenarians with Pulmonary Nodules = 2 cm?
Ann Surg Oncol. 2024;31:1585-1586.
PubMed
CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground
Glass-Predominant Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:1536-1545.
PubMed
Abstract available
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2024 Feb 3:S0003-4975(24)00080.
PubMed
Abstract available
Influence of Respiratory Motion on Dose Distribution in Gastric Mucosa-associated
Lymphoid Tissue Lymphoma Radiotherapy.
Anticancer Res. 2024;44:687-694.
PubMed
Abstract available
Investigation of Mirna-223-3p Expression in Non-small Cell Lung Cancers.
Anticancer Res. 2024;44:585-591.
PubMed
Abstract available
CCR10-mediated Enhancement of T Cell Trafficking for Improved Tumor
Immunotherapy.
Anticancer Res. 2024;44:521-532.
PubMed
Abstract available
Large Inflammatory Myofibroblastic Tumor of the Lung in a Pediatric Patient.
Arch Bronconeumol. 2024;60:103-104.
PubMed
Endobronchial Ultrasound: Detection of Lung Adenocarcinoma and Unmasking of
Superior Vena Cava Thrombosis. An Exceptional Case.
Arch Bronconeumol. 2024;60:113.
PubMed
Pulmonary Malt Lymphoma With Amyloidosis: An Uncommon Pulmonary Entity.
Arch Bronconeumol. 2024;60:107-108.
PubMed
Carcinosarcoma: A Rare Lung Tumor.
Arch Bronconeumol. 2024;60:109.
PubMed
Multi-omics sequencing revealed endostar combined with cisplatin treated non
small cell lung cancer via anti-angiogenesis.
BMC Cancer. 2024;24:187.
PubMed
Abstract available
Identifying optimal ALK inhibitors in first- and second-line treatment of
patients with advanced ALK-positive non-small-cell lung cancer: a systematic
review and network meta-analysis.
BMC Cancer. 2024;24:186.
PubMed
Abstract available
Anticipated time to seek medical advice for possible lung cancer symptoms and
barriers to timely presentation in Palestine: a national cross-sectional study.
BMC Cancer. 2024;24:183.
PubMed
Abstract available
Response to immune checkpoint inhibitor combination therapy in metastatic
RET-mutated lung cancer from real-world retrospective data.
BMC Cancer. 2024;24:178.
PubMed
Abstract available
A real-world cohort study of first-line afatinib in patients with EGFR-mutant
advanced non-small cell lung cancer in Vietnam.
BMC Cancer. 2024;24:176.
PubMed
Abstract available
Effectiveness of CT radiomic features combined with clinical factors in
predicting prognosis in patients with limited-stage small cell lung cancer.
BMC Cancer. 2024;24:170.
PubMed
Abstract available
Phase II trial of afatinib in patients with advanced urothelial carcinoma with
genetic alterations in ERBB1-3 (LUX-Bladder 1).
Br J Cancer. 2024;130:434-441.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Increase in the Life Expectancy of Patients with Cancer in the United States.
Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
PubMed
Abstract available
The Influence of Smoking and Occupational Risk Factors on DNA Methylation in the
AHRR and F2RL3 Genes.
Cancer Epidemiol Biomarkers Prev. 2024;33:224-233.
PubMed
Abstract available
The interplay between autophagy and apoptosis: its implication in lung cancer and
therapeutics.
Cancer Lett. 2024 Feb 1:216662. doi: 10.1016/j.canlet.2024.216662.
PubMed
Abstract available
Arginine methylation-dependent cGAS stability promotes non-small cell lung cancer
cell proliferation.
Cancer Lett. 2024 Feb 6:216707. doi: 10.1016/j.canlet.2024.216707.
PubMed
Abstract available
Integrating AI-powered digital pathology and imaging mass cytometry identifies
key classifiers of tumor cells, stroma, and immune cells in non-small cell lung
cancer.
Cancer Res. 2024 Feb 5. doi: 10.1158/0008-5472.CAN-23-1698.
PubMed
Abstract available
Body mass index and lung cancer risk: Pooled analysis of 10 prospective cohort
studies in Japan.
Cancer Sci. 2024 Feb 4. doi: 10.1111/cas.16093.
PubMed
Abstract available
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in
Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated
Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.
Clin Lung Cancer. 2024 Jan 6:S1525-7304(23)00267.
PubMed
Abstract available
So Now We Know-Reflections on the Extent of Resection for Stage I Lung Cancer.
Clin Lung Cancer. 2023 Dec 28:S1525-7304(23)00262.
PubMed
Abstract available
Malignant Peritoneal Mesothelioma Complicating Familial Mediterranean Fever on
18F-FDG PET/CT.
Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005041.
PubMed
Abstract available
Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome
and novel predictive markers.
Eur J Cancer. 2023;198:113495.
PubMed
Abstract available
C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with
tumor-associated macrophages to facilitate metastatic potential after radiation.
Eur J Cancer. 2024;198:113521.
PubMed
Abstract available
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell
lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the
multicenter, single-arm phase II trial SAKK 19/17.
Eur J Cancer. 2024;200:113600.
PubMed
Abstract available
Impact of intrapulmonary tumor location of non-small cell lung cancer on surgical
outcomes for segmentectomy.
Eur J Cardiothorac Surg. 2024 Feb 3:ezae036. doi: 10.1093.
PubMed
Abstract available
Which extent of surgical resection thoracic surgeons would choose if they were
diagnosed with an early-stage lung cancer: a European survey.
Eur J Cardiothorac Surg. 2024;65:ezae015.
PubMed
CircBRIP1: a plasma diagnostic marker for non-small-cell lung cancer.
J Cancer Res Clin Oncol. 2024;150:83.
PubMed
Abstract available
Detection of the DNA methylation of seven genes contribute to the early diagnosis
of lung cancer.
J Cancer Res Clin Oncol. 2024;150:77.
PubMed
Abstract available
Patterns and trends of mortality from metastatic colorectal cancer in Shanghai,
China from 2005 to 2021: a population-based retrospective analysis.
J Cancer Res Clin Oncol. 2024;150:68.
PubMed
Abstract available
Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus
Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung
Cancer.
J Clin Oncol. 2024 Feb 7:JCO2301521. doi: 10.1200/JCO.23.01521.
PubMed
Abstract available
Racial and ethnic disparities in genomic testing among lung cancer patients: a
systematic review.
J Natl Cancer Inst. 2024 Feb 6:djae026. doi: 10.1093.
PubMed
Abstract available
Video-assisted mediastinoscopic lymphadenectomy (VAMLA): mature results for
staging non-small cell lung cancer with normal mediastinum.
J Thorac Cardiovasc Surg. 2024 Feb 2:S0022-5223(24)00098.
PubMed
Abstract available
Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the
Comprehensive Morphologic Assessment.
J Thorac Oncol. 2024;19:273-284.
PubMed
Abstract available
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current
Evidence and Future Challenges.
J Thorac Oncol. 2024;19:199-215.
PubMed
Abstract available
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT
Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2
Randomized Study.
J Thorac Oncol. 2024;19:285-296.
PubMed
Abstract available
Global burden of lung cancer attributable to household fine particulate matter
pollution in 204 countries and territories, 1990-2019.
J Thorac Oncol. 2024 Feb 2:S1556-0864(24)00034.
PubMed
Abstract available
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M
Descriptors in the Forthcoming 9th edition of the TNM Classification of Lung
Cancer.
J Thorac Oncol. 2024 Feb 4:S1556-0864(24)00060.
PubMed
Abstract available
The Joint Problem of Rheumatoid Arthritis and Lung Cancer.
J Thorac Oncol. 2024;19:196-198.
PubMed
An Error in Modeling and the Selection of Independent Radiomics Variables Need
Caution.
J Thorac Oncol. 2024;19:344-345.
PubMed
Real-World Evidence of the Association Between Rheumatoid Arthritis and Lung
Cancer.
J Thorac Oncol. 2024;19:346.
PubMed
Information Bias Might Exaggerate Lung Cancer Risk of Patients With Rheumatoid
Arthritis.
J Thorac Oncol. 2024;19:348.
PubMed
A Paradigm Shift in First-Line Treatment Can Have Many Implications For
Second-Line Treatment.
J Thorac Oncol. 2024;19:350.
PubMed
A Response to the Letter to the Editor: "A Paradigm Shift in First-Line Treatment
Can Have Many Implications for Second-Line Treatment".
J Thorac Oncol. 2024;19:351-352.
PubMed
Pembrolizumab plus chemotherapy for advanced gastric cancer.
Lancet Oncol. 2024;25:e50.
PubMed
Pembrolizumab plus chemotherapy for advanced gastric cancer.
Lancet Oncol. 2024;25:e51.
PubMed
Pembrolizumab plus chemotherapy for advanced gastric cancer - Authors' reply.
Lancet Oncol. 2024;25:e52.
PubMed
Real-World comprehensive genomic profiling data for diagnostic clarity in
pulmonary Large-Cell neuroendocrine carcinoma.
Lung Cancer. 2024;188:107454.
PubMed
Abstract available
Prognostic value of predominant subtype in pathological stage II-III lung
adenocarcinoma with epidermal growth factor receptor mutation.
Lung Cancer. 2024;188:107453.
PubMed
Abstract available
SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated
with (18)F-FDG metabolic parameters.
Lung Cancer. 2024;188:107449.
PubMed
Abstract available
Real-world outcomes associated with afatinib use in patients with solid tumors
harboring NRG1 gene fusions.
Lung Cancer. 2024;188:107469.
PubMed
Abstract available
Incorporation of the lepidic component as an additional pathological T descriptor
for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma.
Lung Cancer. 2024;189:107472.
PubMed
Abstract available
Clinical application of the Lung Cancer Compact Panel(TM) using various types of
cytological specimens in patients with lung cancer.
Lung Cancer. 2024;189:107498.
PubMed
Abstract available
VTE with Amivantamab plus Chemotherapy in NSCLC. Reply.
N Engl J Med. 2024;390:579-580.
PubMed
VTE with Amivantamab plus Chemotherapy in NSCLC.
N Engl J Med. 2024;390:578-579.
PubMed
The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus
chemotherapy for non-small cell lung cancer: An updated systematic review and
meta-analysis.
PLoS One. 2024;19:e0276318.
PubMed
Abstract available
Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the
treatment of non-small cell lung cancer.
PLoS One. 2024;19:e0295966.
PubMed
Abstract available
Transforming lung cancer types.
Science. 2024;383:590-591.
PubMed
Abstract available
Thank you for your interest in scientific medicine.